An observational study in Cornea Transplant, sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-02-17.
Sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Observational
Evaluate the well-being of patients and clinicl outcomes of the cornea after transplantation
The study aims to evaluate patients affected by corneal diseases who will undergo corneal transplantation.
The evaluation will be carried out pre and post transplantation to evaluate the clinical outcome of the patients and the quality of life and functional anatomical recovery.
IRCCS Azienda Ospedaliero-Universitaria di Bologna is the lead sponsor of 493 studies on the registry; 273 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population consists of patients with corneal disease who will undergo corneal transplantation.
Exclusion Criteria:
Anatomical recovery after corneal transplant
Anatomical recovery will be assessed by the regularity of the cornea.
Time frame: postoperatively at 7 days, 30 days, 3 months, and 12 months.
Visual-functional recovery after corneal transplant
Visus examination
Time frame: postoperatively at 7 days, 30 days, 3 months, and 12 months.
Patients's quality of life
Administration to patients of Health-related SF12 questionnaire
Time frame: One week before surgery and at seven days, thirty days, three months, six months, one year, two years, three years, and four years after surgery.
Patients's quality of life
Administration to patients of Schedule for the Evaluation of Individual Quality of Life (SEI-QoL) questionnaire
Time frame: One week before surgery and at seven days, thirty days, three months, six months, one year, two years, three years, and four years after surgery.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
IRCCS Azienda Ospedaliero-Universitaria di Bologna